SUPRIYA — Supriya Lifescience Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for Supriya Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,854	5,300	4,609	5,704	6,965
Cost of Revenue
Gross Profit	2,448	3,163	2,540	3,129	4,480
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,247	3,257	3,438	4,132	4,561
Operating Profit	1,606	2,043	1,172	1,572	2,404
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,674	2,072	1,235	1,657	2,485
Provision for Income Taxes
Net Income After Taxes	1,238	1,518	899	1,191	1,880
Net Income Before Extraordinary Items
Net Income	1,238	1,518	899	1,191	1,880
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1,238	1,518	899	1,191	1,880
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	15.4	18.8	11.8	15.4	24.2
Dividends per Share